Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
The Emerging Role of Fusion Inhibitors in HIV Infection — De Clercq Erik (1999) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
The Emerging Role of Fusion Inhibitors in HIV Infection
Shared by
De Clercq Erik
KU Leuven
The Emerging Role of Fusion Inhibitors in HIV Infection
Article
1999
en
Related publications
Article
2020
The emerging role of BET inhibitors in breast cancer
Αngeliki Andrikopoulou
,
Michalis Liontos
,
Konstantinos Koutsoukos
,
Meletios A Dimopoulos
,
Flora Zagouri
Article
2011
The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment
Shahneen Sandhu
,
Timothy A. Yap
,
Johann S. de Bono
Authors
De Clercq Erik
KU Leuven
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Article
1999
Perspectives of non-nucleoside reverse transcriptase inhibitors (NNRTIs) in the therapy of HIV-1 infection
De Clercq Erik
Article
2021
Emerging Role of PD-1/PD-L1 Inhibitors in Chronic Liver Diseases
Vishakha Singh
,
Amit Khurana
,
Prince Allawadhi
,
Anil Kumar Banothu
,
Kala Kumar Bharani
,
Ralf Weiskirchen
Article
1999
ChemInform Abstract: Perspectives of Non‐Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) in the Therapy of HIV‐1 Infection
De Clercq Erik
Discussion(0)
No comments yet. Be the first to comment.